Latest Supply Agreements News

Clarity Pharmaceuticals has expanded its breast cancer pipeline by introducing 64/67Cu-SAR-trastuzumab, supported by promising pre-clinical data and a new supply agreement for trastuzumab, aiming to address the unmet needs in HER2-positive breast cancer treatment.

Lithium Universe Limited has signed a non-binding MOU with Lafarge Canada for exclusive supply of aluminosilicate from its Bécancour refinery, aiming to boost cement durability and sustainability in Canada’s growing market.

Firebird Metals has inked a non-binding MoU with global mining giant Eramet to supply manganese ore for its upcoming battery-grade manganese plant in China, marking a pivotal step toward production. The agreement aims to evolve into a long-term supply contract by 2026, underpinning Firebird’s growth in the EV battery materials market.

Cue Energy Resources has pushed back the deadline for its gas supply agreement with Arafura from early February to the end of March 2025, signaling a critical timeline shift for the Nolans rare earths project.

Echelon Resources has extended the condition precedent date for its Gas Supply Agreement with Arafura Rare Earths to 31 March 2025, signaling a cautious but steady approach to project timelines.

WA Kaolin Ltd has marked a pivotal operational milestone in Q4 2024 with the successful commissioning of its classifier project, boosting production and product quality. The company is now poised for growth with increasing sales and a planned equity capital raising.

BPH Global Limited secured $325,000 in funding during the December quarter, progressing its Indonesian seaweed venture and renewing key R&D partnerships. The company ends the quarter with $226,000 cash on hand and plans a $1 million capital raise at an upcoming EGM.

Admiralty Resources NL has marked a significant production milestone at its Mariposa Iron Ore Project in Chile, securing a sales agreement for 80,000 tonnes of iron ore amid ongoing operational and environmental progress.

Central Petroleum Limited reported a solid quarter ending December 31, 2024, driven by increased gas production from new wells and a restructured loan facility that enhances financial flexibility.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Elementos Limited reports significant progress in its Oropesa and Cleveland tin projects, positioning itself as a key supplier in Europe amid tightening global tin markets.

ABx Group reports significant progress in its rare earths and bauxite ventures, including enhanced geological models and pilot plant developments supported by key partnerships and government backing.